Flatiron Health, Inc.

Flatiron Health is a health technology company dedicated to improving cancer care and advancing research by creating a more modern, connected oncology ecosystem. Founded in 2012, its mission is to improve and extend lives by learning from the experience of every person with cancer. The company's headquarters are located in New York, USA.

Flatiron Health offers a suite of oncology-specific software and data solutions. Key products include OncoEMR for electronic medical records, Flatiron Assist for clinical decision support, OncoTrials for patient recruitment in clinical trials, and Flatiron Clinical Pipe for streamlined data transfer. The company also provides real-world data and evidence solutions for life sciences organizations, notably through its AI-powered platform, Flatiron Telescope, which delivers oncology insights. Flatiron Health serves various market segments, partnering with community cancer practices, academic research centers, and therapeutic oncology companies.

Nathan Hubbard serves as the Chief Executive Officer of Flatiron Health. In late 2025, Paradigm Health acquired Flatiron's clinical research business, including OncoEMR and Clinical Pipe, while Flatiron Health continues to operate as an independent affiliate of the Roche Group, which acquired the company in 2018. Flatiron Health recently launched Flatiron Telescope, an AI platform for oncology insights, and presented extensive research at ASCO 2026, showcasing its commitment to leveraging technology and data to transform cancer care.